ABBVIE A/S: Financial statements 2013
CVR: 34462828
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
ABBVIE A/S (CVR 34462828) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 525,506,337 and a net result of DKK 10,590,713. The profit margin was 2%. Equity in the 2013 report amounted to DKK 57,990,247. The solvency ratio was 25.7%. The company had 83 employees in the financial year.
- Revenue
- DKK 525,506,337
- Gross Profit
- DKK 93,850,240
- Profit/Loss
- DKK 10,590,713
- Equity
- DKK 57,990,247
- Total Assets
- DKK 226,027,613
- Employees
- 83
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
ABBVIE A/S has published its interim report for the period March 14, 2012 – December 31, 2012.
As of June 7, 2013, EY Danmark A/S has been appointed auditor of ABBVIE A/S.
As of June 7, 2013, JUT NR. 2180 A/S has been appointed auditor of ABBVIE A/S.
As of June 7, 2013, EY Danmark A/S has stepped down as auditor of ABBVIE A/S.
As of June 7, 2013, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of ABBVIE A/S.
As of January 1, 2013, William Joseph Chase has joined the board of directors of ABBVIE A/S.
As of January 1, 2013, Thomas Craig Freyman has left the board of directors of ABBVIE A/S.
About ABBVIE A/S
ABBVIE A/S is a Danish company of the type Aktieselskab based in København N, founded in 2012. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named WCA PHARMACEUTICALS A/S. The management consists of Thea Larsen. The board consists of Matthew Robert Iles (chair), Arnaud Jean Jacques Coint-Bavarot, Jens Lange and Shitra Irari Amozurrutia Blancas. The company is owned by AbbVie Central Finance B.V.. The company has 59 employees (2026). In 2025, the company reported revenue of DKK 472,957,984 and a net result of DKK 25,023,523 compared with DKK 11,055,919 the year before. Equity in the 2025 report amounted to DKK 98,011,918.